SHC
Sotera Health Company · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow +2.1% ·
net new positions +7.1%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 93 | -4 | 114.64M | $2.03B | +6 | −9 |
| Q1 2026 | 99 | +7 | 101.03M | $1.45B | +12 | −6 |
| Q4 2025 | 93 | +4 | 88.33M | $1.56B | +5 | — |
| Q3 2025 | 15 | -1 | 46.41M | $729.96M | — | −2 |
| Q2 2025 | 14 | +1 | 41.75M | $464.28M | +2 | −1 |
| Q1 2025 | 10 | +3 | 12.24M | $142.70M | +3 | — |
| Q4 2024 | 7 | -3 | 12.67M | $173.20M | — | −3 |
| Q3 2024 | 9 | -1 | 11.24M | $187.78M | +1 | −2 |
| Q2 2024 | 10 | — | 8.23M | $97.70M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 14.91M | — | $165.80M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 14.91M | — | $165.80M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 14.91M | — | $165.80M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 14.91M | — | $165.80M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passive) | 14.91M | — | $165.80M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passive) | 13.72M | — | $152.56M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passive) | 4.54M | 0.0% | $50.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 3.10M | +18.1% | $34.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passive) | 2.91M | +1.9% | $32.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passive) | 2.91M | +1.9% | $32.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Norges Bank ✦ (passive) | 863.94K | -23.8% | $9.61M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Millennium Management ✦ | 524.56K | +2038.6% | $5.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 424.47K | +28.6% | $4.72M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Greenlight Capital (DME Capital) ✦ | 233.69K | New | $2.60M | 0.1% | New | 1 | SEC ↗ |
| 28 | Greenlight Capital (DME Capital) ✦ | 233.69K | New | $2.60M | 0.1% | New | 1 | SEC ↗ |
| 29 | Point72 Asset Management ✦ | 180.37K | New | $2.01M | 0.0% | New | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 127.45K | -67.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 127.45K | -67.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 127.45K | -67.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 127.45K | -67.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 127.45K | -67.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 100.53K | +3.0% | $1.12M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Citadel Advisors ✦ | 88.04K | +22.8% | $978,971 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 26.88K | — | $298,929 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 26.88K | — | $298,929 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Greenlight Capital (DME… | $2.60M | 0.1% |
| Greenlight Capital (DME… | $2.60M | 0.1% |
| Point72 Asset Management | $2.01M | 0.0% |
Exited
| Marshall Wace | $1.92M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 293 holders, 275.22M shares, $3.76B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 294.51K sh · $5.45M
Officer, Director · 850.00K sh · $15.73M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology